Antibody Fragments Market: By Product Type (F(ab) fragment, F(ab’)2 fragment), By Application (Cancer, Immunodeficiency Disorders, Others) and Geography  

Purchase Option

$ 4400
$ 6600
$ 8900

Antibody Fragments Market size was valued at USD 16,450.0 million in 2022 and is poised to grow at a CAGR of  8.7% from 2023-29. Due to increase in prevalence of various types of cancer, immunodeficiency disorders, and other infectious diseases. Antibody fragments are parts of full-length antibodies that have been digested by papain or pepsin. The market is still in its early phases, and the majority of current antibody fragments research is focused on cancer and related disorders. Moreover, rise in global geriatric population, wide range of applications with the antibody fragments, and rise in R&D activities for the development of antibody fragments are the major factors that are driving the growth of the global antibody fragments market over the forecast timeframe. This report studies global market dynamics elaborately to indentify the current trends & drivers, future opportunities and possible challenges to the key stakeholders operating in the market. Global market report includes human demographics; regulatory scenario, and competition analysis with vividly illustrated the competition dashboard to assess the market competition. Moreover, PBI analyzed global antibody fragments market to better equip clients with possible investment opportunities across the regions (regional Investment Hot-Spots) and market unmet needs (Product Opportunities). The market for antibody fragments is being pushed by the rising prevalence of target diseases, the benefits of antibody fragments over full-length antibodies, and increased R&D spending. The tight regulatory standards for the approval of antibody fragments, as well as challenges in the purification of antibody fragments, are projected to stifle market expansion.

Antibody Fragments Market Summary

Study Period

2024-2030

Base Year

2023

CAGR

8.7%

Largest Market

North America

Fastest Growing Market

Europe
Antibody Fragments Market Dynamics

Increase in the prevalence of cancer, immunodeficiency disorders, and infectious diseases is a key factor drive the global antibody fragments market. According to World Health Organization 2018, approximately 9.6 Mn death occurred due to cancer around the globe. moreover, product approval by the FDA for antibodies fragment, raise in funding for the R&D activities by public and private sectors are anticipated to propel the global antibody fragments market over the forecast years.

Key Features of the Reports

  • The report provides granular level information about the market size, regional market share, historic market (2018-2022) and forecast (2023-2029)
  • The report covers in-detail insights about the competitors overview, company share analysis, key market developments, and their key strategies
  •  The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
  • The report tracks recent innovations, key developments and startups details that are actively working in the market
  • The report provides plethora of information about market entry strategies, regulatory framework and reimbursement scenario
  • The report analyses the impact of socio-political environment through PESTLE Analysis and competition through Porters Five Force Analysis in addition to recent technology advancements and innovations in the market

Antibody Fragments Market Segmentation

By Product Type
  • F(ab) fragment
  • F(ab)2 fragment
By Application
  • Cancer
  • Immunodeficiency Disorders
  • Others

Frequently Asked Questions

The key segments covered in the antibody fragments market are: by product type, application, and geography

The antibody fragments market has been classified into North America, Asia Pacific, Europe, Latin America, Middle East and Africa, and the rest of MEA.

The antibody fragments market key players are: Bristol-Myers Squibb Company (U.S.), Eli Lilly and Company (U.S.), F. Hoffmann-La Roche Ltd. (Switzerland), Novartis AG (Switzerland)

1. Executive Summary
2. Global Antibody Fragments Market Introduction 
2.1.Global Antibody Fragments Market  - Taxonomy
2.2.Global Antibody Fragments Market  - Definitions
2.2.1.Product Type
2.2.2.Application
2.2.3.Region
3. Global Antibody Fragments Market Dynamics
3.1. Drivers
3.2. Restraints
3.3. Opportunities/Unmet Needs of the Market
3.4. Trends
3.5. Product Landscape
3.6. New Product Launches
3.7. Impact of COVID 19 on Market
4. Global Antibody Fragments Market Analysis, 2018 - 2022 and Forecast 2023 - 2029
4.1.  Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
4.2.  Year-Over-Year (Y-o-Y) Growth Analysis (%) 
4.3.  Market Opportunity Analysis 
5. Global Antibody Fragments Market  By Product Type, 2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million)
5.1. F(ab) fragment
5.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
5.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.1.3. Market Opportunity Analysis 
5.2. F(ab)2 fragment
5.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
5.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.2.3. Market Opportunity Analysis 
6. Global Antibody Fragments Market  By Application, 2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million)
6.1. Cancer
6.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
6.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.1.3. Market Opportunity Analysis 
6.2. Immunodeficiency Disorders
6.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
6.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.2.3. Market Opportunity Analysis 
6.3. Others
6.3.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
6.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.3.3. Market Opportunity Analysis 
7. Global Antibody Fragments Market  By Region, 2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million)
7.1. North America
7.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
7.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.1.3. Market Opportunity Analysis 
7.2. Europe
7.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
7.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.2.3. Market Opportunity Analysis 
7.3. Asia Pacific (APAC)
7.3.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
7.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.3.3. Market Opportunity Analysis 
7.4. Middle East and Africa (MEA)
7.4.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
7.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.4.3. Market Opportunity Analysis 
7.5. Latin America
7.5.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
7.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.5.3. Market Opportunity Analysis 
8. North America Antibody Fragments Market ,2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million)
8.1. Product Type Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
8.1.1.F(ab) fragment
8.1.2.F(ab)2 fragment
8.3.  Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
8.3.1.United States of America (USA)
8.3.2.Canada
9. Europe Antibody Fragments Market ,2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million)
9.1. Product Type Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
9.1.1.F(ab) fragment
9.1.2.F(ab)2 fragment
9.2.  Application Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
9.2.1.Cancer
9.2.2.Immunodeficiency Disorders
9.2.3.Others
9.3.  Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
9.3.1.Germany
9.3.2.France
9.3.3.Italy
9.3.4.United Kingdom (UK)
9.3.5.Spain
9.3.6.Rest of EU
10. Asia Pacific (APAC) Antibody Fragments Market ,2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million)
10.1. Product Type Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.1.1.F(ab) fragment
10.1.2.F(ab)2 fragment
10.2.  Application Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.2.1.Cancer
10.2.2.Immunodeficiency Disorders
10.2.3.Others
10.3.  Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.3.1.China
10.3.2.India
10.3.3.Australia and New Zealand (ANZ)
10.3.4.Japan
10.3.5.Rest of APAC
11. Middle East and Africa (MEA) Antibody Fragments Market ,2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million)
11.1. Product Type Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.1.1.F(ab) fragment
11.1.2.F(ab)2 fragment
11.2.  Application Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.2.1.Cancer
11.2.2.Immunodeficiency Disorders
11.2.3.Others
11.3.  Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.3.1.GCC Countries
11.3.2.South Africa
11.3.3.Rest of MEA
12. Latin America Antibody Fragments Market ,2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million)
12.1. Product Type Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.1.1.F(ab) fragment
12.1.2.F(ab)2 fragment
12.2.  Application Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.2.1.Cancer
12.2.2.Immunodeficiency Disorders
12.2.3.Others
12.3.  Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.3.1.Brazil
12.3.2.Mexico
12.3.3.Rest of LA
13. Competition Landscape
13.1.  Market Player Profiles (Introduction, Brand/Product Sales, Financial Analysis, Product Offerings, Key Developments, Collaborations, M & A, Strategies, and SWOT Analysis) 
13.2.1.Bristol-Myers Squibb Company (U.S.)
13.2.2.Eli Lilly and Company (U.S.)
13.2.3.F. Hoffmann-La Roche Ltd. (Switzerland)
13.2.4.Novartis AG (Switzerland)
13.2.5.Johnson & Johnson Services, Inc. (U.S.)
13.2.6.Amgen, Inc. (U.S.)
14. Research Methodology 
15. Appendix and Abbreviations 
  • Bristol-Myers Squibb Company (U.S.)
  • Eli Lilly and Company (U.S.)
  • F. Hoffmann-La Roche Ltd. (Switzerland)
  • Novartis AG (Switzerland)
  • Johnson & Johnson Services, Inc. (U.S.)
  • Amgen, Inc. (U.S.)
  • AbbVie, Inc. (U.S.)
  • Takeda Pharmaceutical Company Limited (Japan)
  • Sanofi S.A. (France)
  • Biogen, Inc. (U.S.)

Adjacent Markets